Company intelligence / Profile preview
Xinjiang Deyuan Bioengineering Co., Ltd.
Xinjiang Uygur Zizhiqu, Chinaxjdysw.com.cn ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Company manufactures and sells approved plasma-derived immunoglobulin products for infectious and immune system diseases.
- Therapeutic areas
- HematologyImmunologyInfectious Diseases
- Modalities
- Immunoglobulin
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
03
Partnerships
China Biologic Products Holdings, Inc. (historical plasma supply, now disputed)Southern Shuanglin Bio-Pharmacy Co., Ltd. (plasma supply)
Beyond the preview
Go deeper on Xinjiang Deyuan Bioengineering Co., Ltd..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Xinjiang Deyuan Bioengineering Co., Ltd..